» Articles » PMID: 27292223

In vivo Evidence for a Limited Role of Proximal Tubular Klotho in Renal Phosphate Handling

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 2016 Jun 14
PMID 27292223
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Klotho is a transmembrane protein expressed in the renal tubules where it acts as a permissive coreceptor for fibroblast growth factor 23 (FGF23). FGF23 signaling reduces the abundance of CYP27b1 and phosphate cotransporters NPT2a and NPT2c, leading to a decrease in 1,25(OH)2D3 synthesis and a rise in urinary phosphate excretion, respectively. Systemic or whole-nephron deletion of Klotho in mice results in renal FGF23 resistance characterized by high 1,25(OH)2D3 and phosphate levels and premature aging. Expression of Klotho is highest in the distal tubules, whereas 25OH vitamin D 1α hydroxylation and phosphate reabsorption predominantly occur in the proximal tubules. Currently, the segment-specific roles of Klotho in renal tubules are not fully understood. Here we have generated mice with Klotho specifically ablated from the proximal tubules using 3 different Cre mouse strains. All 3 models displayed impaired urinary phosphate excretion and increased abundance of NPT2a in the brush border membrane. Notably, hyperphosphatemia in knockout mice was mild or nonexistent under basal conditions but occurred upon high phosphate loading, indicating the presence of compensatory mechanisms. Effects on 1,25(OH)2D3 varied between mouse strains but were modest overall. Thus, Klotho expressed in the proximal tubules has a defined but limited role in renal phosphate handling in vivo.

Citing Articles

The Intricacies of Renal Phosphate Reabsorption-An Overview.

Walker V Int J Mol Sci. 2024; 25(9).

PMID: 38731904 PMC: 11083860. DOI: 10.3390/ijms25094684.


Emerging concepts on the FGF23 regulation and activity.

Rivoira M, Peralta Lopez M, Areco V, Diaz de Barboza G, Dionisi M, Tolosa de Talamoni N Mol Cell Biochem. 2024; 480(1):75-89.

PMID: 38581553 DOI: 10.1007/s11010-024-04982-6.


Correlation between soluble klotho and chronic kidney disease-mineral and bone disorder in chronic kidney disease: a meta-analysis.

Fan Z, Wei X, Zhu X, Yang K, Tian L, Du Y Sci Rep. 2024; 14(1):4477.

PMID: 38396063 PMC: 10891172. DOI: 10.1038/s41598-024-54812-4.


Klotho's impact on diabetic nephropathy and its emerging connection to diabetic retinopathy.

Tang A, Zhang Y, Wu L, Lin Y, Lv L, Zhao L Front Endocrinol (Lausanne). 2023; 14:1180169.

PMID: 37143722 PMC: 10151763. DOI: 10.3389/fendo.2023.1180169.


The impact of SGLT2 inhibitors on αKlotho in renal MDCK and HK-2 cells.

Wolf L, Foller M, Feger M Front Endocrinol (Lausanne). 2023; 14:1069715.

PMID: 36967770 PMC: 10032406. DOI: 10.3389/fendo.2023.1069715.